Annals of Surgical Oncology, Vol 5, Issue 4 322-328, Copyright © 1998 by Society of Surgical Oncology

ARTICLES

Surgical margins and prognostic factors in patients with thick (>4mm) primary melanoma

K. M. Heaton, J. J. Sussman, J. E. Gershenwald, J. E. Lee, D. S. Reintgen, P. F. Mansfield and M. I. Ross
The University of Texas M.D. Anderson Cancer Center, Houston 77030, USA.

BACKGROUND: Randomized trials have demonstrated the efficacy of 1- and 2-cm excision margins for thin and intermediate-thickness melanomas, respectively. The optimal margin of excision for thick melanomas is still unknown, however. We evaluated whether the margins used for intermediate-thickness melanomas can be applied safely to thicker lesions. METHODS: The charts of 278 patients with thick primary melanomas treated between 1985 and 1996 were retrospectively reviewed. Patients with distant metastases at presentation or with follow-up less than 6 months were excluded. Median follow-up was 27 months. Known melanoma prognostic factors and excision margins were evaluated for their impact on local recurrence (LR), disease-free survival (DFS), and overall survival (OS). RESULTS: Median tumor thickness was 6.0 mm, and 57% were ulcerated. At presentation, 201 patients (72%) were node negative and 77 (28%) were node positive (palpable or occult). The 5-year OS and DFS rates were 55% and 30%, respectively. The LR rate for all patients was 12%. Although nodal status, thickness, and ulceration were significantly associated with OS by multivariate analysis, neither LR nor excisional margin (<2 cm vs. >2 cm) significantly affected DFS or OS in these patients. CONCLUSIONS: Because margins of excision greater than 2 cm do not improve LR, DFS, or OS compared to a margin of 2 cm or less, a 2-cm margin of excision is adequate for patients with thick melanoma. Because nodal status is a significant prognostic factor in these patients, staging by sentinel node biopsy should be considered in patients with thick melanomas and clinically negative nodal basins to allow proper entry and stratification in adjuvant therapy trials.

This article has been cited by other articles:

				H. Tsao, M. B. Atkins, and A. J. Sober Management of Cutaneous Melanoma N. Engl. J. Med., September 2, 2004; 351(10): 998 - 1012. [Full Text] [PDF]

				G. W. Carlson, D. R. Murray, A. Hestley, C. A. Staley, R. H. Lyles, and C. Cohen Sentinel Lymph Node Mapping for Thick (>=4-mm) Melanoma: Should We Be Doing It? Ann. Surg. Oncol., May 1, 2003; 10(4): 408 - 415. [Abstract] [Full Text] [PDF]

				G. I. Salti, A. Kansagra, M. A. Warso, S. G. Ronan, and T. K. Das Gupta Clinical Node-Negative Thick Melanoma Arch Surg, March 1, 2002; 137(3): 291 - 295. [Abstract] [Full Text] [PDF]

				C. M. Balch, S.-J. Soong, J. E. Gershenwald, J. F. Thompson, D. S. Reintgen, N. Cascinelli, M. Urist, K. M. McMasters, M. I. Ross, J. M. Kirkwood, et al. Prognostic Factors Analysis of 17,600 Melanoma Patients: Validation of the American Joint Committee on Cancer Melanoma Staging System J. Clin. Oncol., August 15, 2001; 19(16): 3622 - 3634. [Abstract] [Full Text] [PDF]

				C. M. Balch, A. C. Buzaid, S.-J. Soong, M. B. Atkins, N. Cascinelli, D. G. Coit, I. D. Fleming, J. E. Gershenwald, A. Houghton Jr, J. M. Kirkwood, et al. Final Version of the American Joint Committee on Cancer Staging System for Cutaneous Melanoma J. Clin. Oncol., August 15, 2001; 19(16): 3635 - 3648. [Abstract] [Full Text] [PDF]

				C. M. Balch, S.-j. Soong, T. Smith, M. I. Ross, M. M. Urist, C. P. Karakousis, W. J. Temple, M. C. Mihm, R. L. Barnhill, W. R. Jewell, et al. Long-Term Results of a Prospective Surgical Trial Comparing 2 cm vs. 4 cm Excision Margins for 740 Patients With 1-4 mm Melanomas Ann. Surg. Oncol., March 1, 2001; 8(2): 101 - 108. [Abstract] [Full Text] [PDF]

				J. D. Wagner, H.-M. Park, J. J. Coleman III, C. Love, and J. T. Hayes Cervical Sentinel Lymph Node Biopsy for Melanomas of the Head and Neck and Upper Thorax Arch Otolaryngol Head Neck Surg, March 1, 2000; 126(3): 313 - 321. [Abstract] [Full Text] [PDF]

				G. W. Carlson, D. R. Murray, R. Greenlee, N. Alazraki, C. Fry-Spray, R. Poole, M. Blais, A. Hestley, and J. Vansant Management of Malignant Melanoma of the Head and Neck Using Dynamic Lymphoscintigraphy and Gamma Probe-Guided Sentinel Lymph Node Biopsy Arch Otolaryngol Head Neck Surg, March 1, 2000; 126(3): 433 - 437. [Abstract] [Full Text] [PDF]